A 6-month prospective randomized double-blind placebo-controlled clinical trial

Recruiting

99 years or below

All

1 Location

Brief description of study

A double-blind study to investigate efficacy and safety of buntanetap compared with placebo in participants with early PD

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 99 years or below
Gender: All

Updated on 10 May 2023. Study ID: 852307

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

A 6-month prospective randomized double-blind placebo-controlled clinical trial investigating the efficacy safety and tolerability of two different doses of buntanetap or placebo in patients with early Parkinsons disease

Brief description of study

Eligibility of study

Find a site

Interested in the study